Yet another awesome PR to make shareholders weeken
Post# of 72440
And as Doc pointed out on the other board, the key to this PR might be in announcing "Kevetrin has delivered robust results against ALL indications tested TO DATE.
Sounds like this INCLUDES human studies....are they seeing efficacy even at the lowest doses???
Leo wasnt kidding when he said the best is yet to come. Wow.